Lipitor® Type 2 Diabetes Lawsuits*

Cory Watson Attorneys is no longer accepting Lipitor Diabetes cases.

Lipitor® (atorvastatin calcium) is prescribed to patients for cholesterol management. Pfizer, Inc., the drug’s manufacturer, markets Lipitor as a medication that can lower the risk of heart attack, stroke, certain types of heart surgery, and chest pains in patients who have, or are at risk for, heart disease. But patients taking the drug can also experience increased blood glucose levels and may face an increased risk of developing Type 2 diabetes.

Lipitor® Linked to Increased Type 2 Diabetes Risk

Lipitor® is part of a class of cholesterol-lowering drugs known as statins. In 2012, the U.S. Food and Drug Administration released a drug safety communication reporting serious health risks for patients using statins, such as Lipitor®, including worsening glycemic control and the development of diabetes. As a result, statin drug packaging was updated with additional information concerning these risks.

Before Lipitor’s 2012 labeling change, the drug’s label information failed to warn patients of any potential relation between changes in blood sugar levels and taking Lipitor. Despite data suggesting that Lipitor was linked to the development of Type 2 diabetes, the drug was marketed as safe and effective.

Never stop taking any medication without first consulting your doctor.

Cory Watson Attorneys is no longer accepting Lipitor Diabetes cases.

Lipitor® is a registered trademark of Pfizer, Inc. and is used here only to identify the product in question.

This law firm is not associated with, sponsored by, or affiliated with Pfizer, Inc. or the U.S. Food and Drug Administration.